Immunome, Inc. (IMNM)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 15.46 |
| Open | 15.47 |
| Bid | 15.28 x 200 |
| Ask | 15.35 x 400 |
| Day's range | 15.02 - 15.60 |
| 52-week range | 4.50 - 30.96 |
| Volume | |
| Avg. volume | 791,462 |
| Market cap | 918.932M |
| Beta (5Y monthly) | 1.66 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Analysts Estimate Immunome, Inc. (IMNM) to Report a Decline in Earnings: What to Look Out for
Immunome (IMNM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
New Strong Sell Stocks for April 4th
IMNM, SLOIF and TMQ have been added to the Zacks Rank #5 (Strong Sell) List on April 4, 2023.
- Simply Wall St.
Immunome, Inc. (NASDAQ:IMNM) surges 7.6%; individual investors who own 42% shares profited along with institutions
Key Insights Significant control over Immunome by individual investors implies that the general public has more power...
© 2024 Yahoo. All rights reserved.